Key result
Impella LP 5.0 successfully bridges biventricular failure to permanent mechanical circulatory support.
Why the study?
Multi-organ failure secondary to bi-ventricular cardiac dysfunction frequently requires circulatory support, but optimal bridging strategies to long-term support remain challenging.
Case Report (n=1)
The Impella LP 5.0 may serve as an effective bridge to permanent circulatory support in patients with bi-ventricular failure.
Answers are grounded in this paper and cite their sources.
May support Impella LP 5.0 bridging feasibility in bi-ventricular failure; leaves open need for prospective validation before practice change.
Multi-organ failure (MOF) secondary to bi-ventricular cardiac dysfunction is a major therapeutic challenge. In addition to aggressive medical therapy, it frequently requires circulatory support with uni- or bi-ventricular assist devices. The Impella LP 5.0 is a new microaxial left ventricular assist device (LVAD). Microaxial LVADs have been used for short-term circulatory support in patients with cardiogenic shock due to myocarditis, post coronary artery bypass grafting (CABG), or during high-risk percutaneous coronary interventions (PCI). We present a case of a patient in bi-ventricular failure successfully bridged to permanent circulatory support. Relative merits of this therapeutic approach are outlined and discussed.
No takes yet. Share an insight, caveat, or question.
Samoukovic et al. (2009) conducted a case report in Bi-ventricular failure (n=1). Impella LP 5.0 was evaluated on Successful bridge to permanent circulatory support. The Impella LP 5.0 microaxial left ventricular assist device was successfully used to bridge a patient with bi-ventricular failure to permanent circulatory support.
Synapse has enriched 10 related papers. Consider them for comparative context: